View in EDS HTML Full Text PDF Full Text

Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial.

Saved in:
Bibliographic Details
Title: Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial.
Authors: O'Brien TJ; Department of Neuroscience, Central Clinical School, Alfred Health, Monash University, Melbourne, Victoria, Australia.; Departments of Medicine and Neurology, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia., Borghs S; UCB Pharma, Slough, UK., He QJ; UCB Pharma, Raleigh, North Carolina., Schulz AL; UCB Pharma, Monheim am Rhein, Germany., Yates S; UCB Pharma, Raleigh, North Carolina., Biton V; Clinical Trials Inc, Little Rock, Arkansas.
Source: Epilepsia [Epilepsia] 2020 Apr; Vol. 61 (4), pp. 636-646. Date of Electronic Publication: 2020 Mar 28.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32221987
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22O'Brien+TJ%22">O'Brien TJ</searchLink>; Department of Neuroscience, Central Clinical School, Alfred Health, Monash University, Melbourne, Victoria, Australia.; Departments of Medicine and Neurology, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Borghs+S%22">Borghs S</searchLink>; UCB Pharma, Slough, UK.<br /><searchLink fieldCode="AU" term="%22He+QJ%22">He QJ</searchLink>; UCB Pharma, Raleigh, North Carolina.<br /><searchLink fieldCode="AU" term="%22Schulz+AL%22">Schulz AL</searchLink>; UCB Pharma, Monheim am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Yates+S%22">Yates S</searchLink>; UCB Pharma, Raleigh, North Carolina.<br /><searchLink fieldCode="AU" term="%22Biton+V%22">Biton V</searchLink>; Clinical Trials Inc, Little Rock, Arkansas.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222983306R%22">Epilepsia</searchLink> [Epilepsia] 2020 Apr; Vol. 61 (4), pp. 636-646. <i>Date of Electronic Publication: </i>2020 Mar 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Science%22">Blackwell Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2983306R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-1167 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200139580%22">00139580 </searchLink><i>NLM ISO Abbreviation: </i>Epilepsia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32221987
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/epi.16484
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 636
    Titles:
      – TitleFull: Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: O'Brien TJ
      – PersonEntity:
          Name:
            NameFull: Borghs S
      – PersonEntity:
          Name:
            NameFull: He QJ
      – PersonEntity:
          Name:
            NameFull: Schulz AL
      – PersonEntity:
          Name:
            NameFull: Yates S
      – PersonEntity:
          Name:
            NameFull: Biton V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2020 Apr
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1528-1167
          Numbering:
            – Type: volume
              Value: 61
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Epilepsia
              Type: main
ResultId 1